Machine Learning‐Assisted Analysis of Sublingual Microcirculatory Dysfunction for Early Cardiovascular Risk Evaluation and Cardiovascular‐Kidney‐Metabolic Syndrome Stage in Patients With Type 2 Diabetes Mellitus

Documenti analoghi

• Proteomic Profiling Captures Residual Cardiovascular Risk Beyond the PREVENT Model in Individuals With Cardiovascular–Kidney–Metabolic Syndrome Stages 2–3
  di: Xuefei Han, et al.
  Pubblicazione: (2026)
• Hyperaldosteronism in the Pathophysiology and Management of Cardiovascular‐Kidney‐Metabolic Syndrome
  di: Evan Zeitler, et al.
  Pubblicazione: (2026)
• Cardiovascular Disease Risk Prediction in Patients With Metabolic Dysfunction‐Associated Steatohepatitis
  di: Joe Hollinghurst, et al.
  Pubblicazione: (2026)
• The Effect of Canagliflozin Dose on Renal and Cardiovascular Outcomes in Type 2 Diabetes and High Cardiovascular Risk
  di: Elias John Elenjickal, et al.
  Pubblicazione: (2026)
• Prevalence of Albuminuria Across Cardiovascular‐Kidney‐Metabolic Phenotypes in the United States
  di: Sophie E. Claudel, et al.
  Pubblicazione: (2026)